IPCA Laboratories Ltd shares plunged 15.7 per cent to their lowest since September 2013.
IPCA Laboratories Ltd shares plunged 15.7 per cent to their lowest since September 2013.
Credit Suisse downgraded the stock to "underperform" from "neutral", citing negative USFDA observations. FDA's observations are on IPCA's Indore facility, Credit Suisse said.
It said two of these observations are critical, and could delay the recovery of US sales for IPCA.
IPCA shares were trading down 10.37 per cent at Rs 668.90 as of 10.25 am.
Copyright: Thomson Reuters 2014
Sign Up with Google
Add us to your Preferences
Set as your preferred source on Google
ADVERTISEMENT
RECOMMENDED FOR YOU
POPULAR
1
Netweb Technologies Gets 'Buy' Rating As ICICI Securities Initiates Coverage
2
Social Media Screening For Visas: What Is Trump Administration Is Looking For In Applicants' Handles
3
Govt To Bring Bill Replacing MGNREGA With New Law Guaranteeing 125 Days Of Wage Employment
4
Stock Market Live: Nifty Above 26,000, Sensex Down Over 200 Points; HDFC Bank, M&M, Bharti Airtel Drag
5